Endothelial nitric oxide synthase haplotypes associated with hypertension do not predispose to cardiac hypertrophy

DNA and Cell Biology

Volumn 29, Issue 4, 2010, Pages 171-176

  Vasconcellos, Vivian ^a   Lacchini, Riccardo ^b   Jacob Ferreira, Anna L B ^b   Sales, Maria L ^b   Ferreira Sae, Maria C ^b   Schreiber, Roberto ^b   Nadruz, Wilson ^b   Tanus Santos, Jose E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; LIPID; NOS3 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; EXON; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT; AGED; AGING; BLOOD; BLOOD PRESSURE; BODY MASS; CARDIOMEGALY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HEART VENTRICLE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT;

ADULT; AGED; AGING; BLOOD PRESSURE; BODY MASS INDEX; CARDIOMEGALY; ECHOCARDIOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEART VENTRICLES; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS;

EID: 77951234165     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2009.0955     Document Type: Article

References (33)

1. Bader, J.S. (2008). Systems approaches for pharmacogenetics and pharmacogenomics. Pharmacogenomics 9, 257-262.
2. Barouch, L.A., Harrison, R.W., Skaf, M.W., Rosas, G.O., Cappola, T.P., Kobeissi, Z.A., Hobai, I.A., Lemmon, C.A., Burnett, A.L., O'Rourke, B., Rodriguez, E.R., Huang, P.L., Lima, J.A., Berkowitz, D.E., and Hare, J.M. (2002). Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416, 337-339.
3. Booz, G.W. (2005). Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system. Hypertension 45, 341-346.
4. Crawford, D.C., and Nickerson, D.A. (2005). Definition and clinical importance of haplotypes. Annu Rev Med 56, 303-320.
5. Dorn, G.W., II. (2007). The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49, 962-970.
6. Flaherty, M.P., Brown, M., Grupp, I.L., Schultz, J.E., Murphree, S.S., and Jones, W.K. (2007). eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression. Cardiovasc Toxicol 7, 165-177.
7. Frey, N., and Olson, E.N. (2003). Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65, 45-79.
8. Kiechle, F.L., and Malinski, T. (1993). Nitric oxide. Biochemistry, pathophysiology, and detection. Am J Clin Pathol 100, 567-575.
9. Lang, R.M., Bierig, M., Devereux, R.B., Flachskampf, F.A., Foster, E., Pellikka, P.A., Picard, M.H., Roman, M.J., Seward, J., Shanewise, J., Solomon, S., Spencer, K.T., St. John Sutton, M., and Stewart, W. (2006). Recommendations for chamber quantification. Eur J Echocardiogr 7, 79-108.
10. Lapu-Bula, R., Quarshie, A., Lyn, D., Oduwole, A., Pack, C., Morgan, J., Nkemdiche, S., Igho-Pemu, P., Onwuanyi, A., Li, R., and Ofili, E. (2005). The 894T allele of endothelial nitric oxide synthase gene is related to left ventricular mass in African Americans with high-normal blood pressure. J Natl Med Assoc 97, 197-205.
11. Lauer, M.S., Anderson, K.M., Larson, M.G., and Levy, D. (1994). A new method for indexing left ventricular mass for differences in body size. Am J Cardiol 74, 487-491.
12. Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B., and Castelli, W.P. (1990). Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322, 1561-1566.
13. Lin, Y., Wang, L.N., Xi, Y.H., Li, H.Z., Xiao, F.G., Zhao, Y.J., Tian, Y., Yang, B.F., and Xu, C.Q. (2008). L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways. Basic Clin Pharmacol Toxicol 103, 124-130.
14. Loyer, X., Heymes, C., and Samuel, J.L. (2008). Constitutive nitric oxide synthases in the heart from hypertrophy to failure. Clin Exp Pharmacol Physiol 35, 483-488.
15. Luizon, M.R., Izidoro-Toledo, T.C., Simoes, A.L., and Tanus-Santos, J.E. (2009). Endothelial nitric oxide synthase polymorphisms and haplotypes in Amerindians. DNA Cell Biol 28, 329-334.
16. Marroni, A.S., Metzger, I.F., Souza-Costa, D.C., Nagassaki, S., Sandrim, V.C., Correa, R.X., Rios-Santos, F., and Tanus-Santos, J.E. (2005). Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12, 177-182.
17. Metzger, I.F., Sertorio, J.T., and Tanus-Santos, J.E. (2007). Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 43, 987-992.
18. Metzger, I.F., Souza-Costa, D.C., Marroni, A.S., Nagassaki, S., Desta, Z., Flockhart, D.A., and Tanus-Santos, J.E. (2005). Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 15, 565-570.
19. Miller, S.A., Dykes, D.D., and Polesky, H.F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16,1215.
20. Sales, M.L., Ferreira, M.C., Leme, C.A., Jr., Velloso, L.A., Gallani, M.C., Colombo, R.C., Franchini, K.G., and Nadruz, W., Jr. (2007). Non-effect of p22-phox -930A/G polymorphism on end-organ damage in Brazilian hypertensive patients. J Hum Hypertens 21, 504-506.
21. Sandrim, V.C., Coelho, E.B., Nobre, F., Arado, G.M., Lanchote, V.L., and Tanus-Santos, J.E. (2006a). Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 186, 428-432.
22. Sandrim, V.C., de Syllos, R.W., Lisboa, H.R., Tres, G.S., and Tanus-Santos, J.E. (2006b). Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 189, 241-246.
23. Sandrim, V.C., de Syllos, R.W., Lisboa, H.R., Tres, G.S., and Tanus-Santos, J.E. (2007). Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 16,348-355.
24. Sandrim, V.C., Palei, A.C., Cavalli, R.C., Araujo, F.M., Ramos, E.S., Duarte, G., and Tanus-Santos, J.E. (2008). eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics 9, 1467-1473.
25. Sandrim, V.C., Yugar-Toledo, J.C., Desta, Z., Flockhart, D.A., Moreno, H., Jr., and Tanus-Santos, J.E. (2006c). Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy. J Hypertens 24, 2393-2397.
26. Shah, A.M., and MacCarthy, P.A. (2000). Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther 86, 49-86.
27. Smith, R.S., Jr., Agata, J., Xia, C.F., Chao, L., and Chao, J. (2005). Human endothelial nitric oxide synthase gene delivery pro- tects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci 76, 2457-2471.
28. Takimoto, E., and Kass, D.A. (2007). Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49, 241-248.
29. Tanus-Santos, J.E., Desai, M., and Flockhart, D.A. (2001). Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11, 719-725.
30. Wenzel, S., Rohde, C., Wingerning, S., Roth, J., Kojda, G., and Schluter, K.D. (2007). Lack of endothelial nitric oxide synthase-derived nitric oxide formation favors hypertrophy in adult ventricular cardiomyocytes. Hypertension 49, 193-200.
31. Xin, Y., Song, X., Xue, H., Liu, Z., Wang, X., Wang, H., Sun, K., Bai, Y., Liu, J., and Hui, R. (2009). A common variant of eNOS gene (Glu298Asp) is an independent risk factor for left ventricular hypertrophy in human essential hypertension. Clin Sci (Lond) 117, 67-73.
32. Yamashita, T., Yamamoto, E., Kataoka, K., Nakamura, T., Matsuba, S., Tokutomi, Y., Dong, Y.F., Ichijo, H., Ogawa, H., and Kim-Mitsuyama, S. (2007). Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency. Hypertension 50, 519-524.
33. Zhu, H., Wang, X., Dong, Y., Treiber, F.A., and Snieder, H. (2005). Influence of the eNOS gene on development of blood pressure and left ventricular mass: longitudinal findings in multiethnic youth. Pharmacogenet Genomics 15, 669-675.